However, direct comparison against semaglutide 2.4mg is still pending in ongoing trials
Key results (52 weeks): Max walking distance 13% (median gain: +26 m) Pain-free walking distance 11% (median gain: +14 m) QoL (VascuQoL-6) improved significantly Lower rates of rescue treatment and (HR 0.46) Effects persisted 5 weeks after treatment stopped Better anklebrachial index, HbA1c, and weight loss (5.2 kg) Safety: Well tolerated Serious adverse events similar to placebo (19% vs 20%) Discontinuation due to AEs: 7% (semaglutide) vs 4% (placebo) No treatment-related deaths How does it compare
Consider using a humidifier in dry environments, particularly during winter months
Stem Cell Therapy for Foot and Ankle Pain At Regenesis, Dr
Your plan is tailored not only to your weight goals, but to your tissue composition, metabolism, and aesthetic timeline
To view a copy of this licence, visit About this article Cite this article Kallala, O., Kacem, S., Fodha, I